NCT00006261 Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer Status WITHDRAWN Phase PHASE2
NCT00006215 Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT00006120 Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT00006104 Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00006038 Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer Status COMPLETED Phase PHASE2
NCT00006010 Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer Status COMPLETED Phase PHASE2
NCT00005963 Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00005960 Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Status UNKNOWN Phase PHASE2
NCT00005958 Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer Status UNKNOWN Phase PHASE2
NCT00005868 Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005857 Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00005810 Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00005800 Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer Status COMPLETED Phase PHASE2
NCT00005627 Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE1
NCT00005096 Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer Status COMPLETED Phase PHASE2
NCT00005086 Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer Status COMPLETED Phase PHASE2
NCT00004923 Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00004913 Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00004906 Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00004888 Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2